Projects and Grants per year
Personal profile
Research Interests
- Ovarian Cancer Screening.
- Chemotherapy Induced Cognitive Impairment.
- Developmental therapeutics in gynecologic cancer.
- Implementation of Precision Medicine.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Residency, Dartmouth College
2006
Doctor of Medicine, University Of Kentucky
2003
Bachelor of Science, University Of Kentucky
1998
Fingerprint
Dive into the research topics where Rachel Miller is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
-
GOG-3091: A Two-Arm Randomized, Double-Blind, Placebo-Controlled Phase 2 Selection Trial to Evaluate the Efficacy and Safety of VB10.16 Alone or in Combination with Atezolizumab in Patients with HPV16-Positive, PD-L1-positive, Recurrent or Metastatic Cerv
Miller, R. (PI)
Gynecological Oncology Group Foundation Incorporated
5/14/24 → 5/14/26
Project: Research project
-
IMGN853-0421/GOG-3078: Randomized, Multicenter, Open-label, Phase 3 study of Mirvetuximab Soravtansine in Combination with Bevacizumab Versus Bevacizumab Alone as Maintenance Therapy for Patients with FRa-positive Recurrent Platinum-sensitive Epithelial o
Miller, R. (PI)
8/30/23 → 8/30/25
Project: Research project
-
A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First-Line Treatment of BRCA Non-Mutated Advanced Epithelial Ovarian Cancer (EOC)
Miller, R. (PI)
Gynecological Oncology Group Foundation Incorporated
2/27/20 → 8/24/25
Project: Research project
-
A Phase 3, Randomized, Double-Blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-Paclitaxel Versus Placebo Plus Carboplatin-Paclitaxel in Patients with Recurrent or Primary Advanced Endometrial Cancer (RUBY)
Miller, R. (PI)
Gynecological Oncology Group Foundation Incorporated
11/15/19 → 1/16/26
Project: Research project
-
Member Institution Purchased Service Agreement
Miller, R. (PI) & Romond, E. (Former PI)
NRG Oncology Foundation Incorporated
3/1/14 → 2/28/25
Project: Research project
Research output
- 1 Meeting Abstract
-
Improving cancer germline testing in rural Appalachian populations with ORIEN
Kolesar, J., Cavnar, M., Miller, R., Pickarski, J., Zhang, S., Nandakumar, K., Schuh, M., Belcher, E., Durbin, E., Poi, M., Ueland, F., Hands, I., Bocklage, T., Jeong, J., Arnold, S. & Evers, M., Jun 2020, In: Cancer Epidemiology Biomarkers and Prevention. 29, 6, 2 p.Research output: Contribution to journal › Meeting Abstract › peer-review